Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ASBP Aspire Biopharma Holdings Inc.

Closed 06-03 16:00:00 EDT

5.84

-0.18

-2.99%

盘后5.55

-0.29-4.97%

19:48 EDT

High5.96	Low5.33	Vol37.83K
Open5.88	D1 Closing6.02	Amplitude10.47%
Mkt Cap7.56M	Tradable Cap596.85K	Total Shares1.30M
T/O217.69K	T/O Rate37.01%	Tradable Shares102.20K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":5.84,"timestamp":1780516800000,"preClose":6.02,"halted":0,"volume":37828,"hourTrading":{"tag":"盘后","latestPrice":5.55,"preClose":5.84,"latestTime":"19:48 EDT","volume":2019,"amount":11206.3864,"timestamp":1780530538683,"change":-0.29,"changeRate":-0.049658,"amplitude":0.056507},"delay":0,"changeRate":-0.029900332225913578,"floatShares":102200,"shares":1295200,"eps":-153.5649,"marketStatus":"Closed","change":-0.18,"latestTime":"06-03 16:00:00 EDT","open":5.88,"high":5.96,"low":5.33,"amount":217691.780012,"amplitude":0.104651,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-153.5649,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780560000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":6.02,"preHourTrading":{"tag":"盘前","latestPrice":5.8295,"preClose":6.02,"latestTime":"09:27 EDT","volume":1517,"amount":8679.743050000001,"timestamp":1780493254693,"change":-0.1905,"changeRate":-0.031645,"amplitude":0.039867},"postHourTrading":{"tag":"盘后","latestPrice":5.55,"preClose":5.84,"latestTime":"19:48 EDT","volume":2019,"amount":11206.3864,"timestamp":1780530538683,"change":-0.29,"changeRate":-0.049658,"amplitude":0.056507},"volumeRatio":0.133788},"requestUrl":"/m/hq/s/ASBP/wiki","defaultTab":"wiki","newsList":[{"id":"2639697851","title":"Aspire Biopharma issues letter to shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697851?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:44","pubTimestamp":1779983079,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) issued the following letter to shareholders from Chief Executive Officer Kraig Higginson. “2026 is shaping up to be a defin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-issues-letter-to-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-issues-letter-to-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638934866","title":"Aspire Biopharma issues shareholder letter to investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2638934866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638934866?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:30","pubTimestamp":1779971444,"startTime":"0","endTime":"0","summary":"Aspire Biopharma posted a shareholder letter from CEO Kraig Higginson outlining 2026 priorities across drug delivery development, consumer supplements, capital actions.Board authorized a USD 5 million share repurchase program; letter cited about USD 21 million net proceeds from a preferred stock private placement.Lead high-dose sublingual aspirin program targeted an NDA filing via the 505 pathway by end-2026; letter also referenced broader patent filings.Binding LOI disclosed April 16, 2026 to buy Dura Driver Control Systems for USD 30 million cash; letter cited 2025 revenue over USD 200 million, Adjusted EBITDA over USD 22 million.Letter stated the DCS deal has a USD 22.5 million financing commitment, not expected to require a new equity raise; link.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL4sQ68L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638500244","title":"Aspire Biopharma unit Buzz Bomb Caffeine partners with EoS Fitness affiliate program","url":"https://stock-news.laohu8.com/highlight/detail?id=2638500244","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638500244?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:30","pubTimestamp":1779885044,"startTime":"0","endTime":"0","summary":"Aspire Biopharma’s wholly owned Buzz Bomb Caffeine unit partnered with HVLP gym chain EoS Fitness via its Flex Deals affiliate program.BUZZ BOMB 50mg sublingual caffeine stick packs will be marketed to EoS members across more than 225 locations open or planned nationwide.Distribution will run through in-gym TV advertising, mobile app offers, on-site product demonstrations, member communications.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL7TLp5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635559480","title":"Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353K","url":"https://stock-news.laohu8.com/highlight/detail?id=2635559480","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635559480?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:47","pubTimestamp":1778885251,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(20.57) per share. This is a 95.93 percent increase over losses of $(504.88) per share from the same period last year.  The company reported $28.353","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620581/aspire-biopharma-hldgs-q1-eps-20-57-up-from-504-88-yoy-sales-28-353k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353K","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635305030","title":"Aspire Biopharma Q1 FY26 net loss narrows to 3.22 million; revenue rises to 28,353","url":"https://stock-news.laohu8.com/highlight/detail?id=2635305030","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635305030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:26","pubTimestamp":1778876770,"startTime":"0","endTime":"0","summary":"Aspire Biopharma posted a net loss of USD 3.22 million for the quarter ended March 31, 2026, narrowing from a net loss of USD 15.94 million a year earlier.Operating loss narrowed to USD 1.65 million from USD 15.56 million, while general and administrative expense fell to USD 1.02 million from USD 15.07 million.Revenue was USD 28,353, with cost of revenue of USD 22,603.Cash was USD 5.86 million at March 31, 2026; management said liquidity is sufficient to fund operations for at least one year after filing, with an additional USD 9 million received in April 2026 from the final tranche of a Series A Convertible Preferred Stock financing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL3WRm21:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634149398","title":"Aspire Biopharma Holdings Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2634149398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634149398?lang=en_us&edition=fundamental","pubTime":"2026-05-09 07:50","pubTimestamp":1778284215,"startTime":"0","endTime":"0","summary":"19:50 EDT Aspire Biopharma (ASBP) Holdings Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633129396","title":"Aspire Biopharma effects 1-for-30 reverse stock split May 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2633129396","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633129396?lang=en_us&edition=fundamental","pubTime":"2026-05-07 23:03","pubTimestamp":1778166208,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings will execute a 1-for-30 reverse stock split effective May 11, 2026, before Nasdaq trading opens.Shares will trade on a post-split basis under existing ticker ASBP.Move targets compliance with Nasdaq minimum bid price requirement.Reverse split expected to cut shares outstanding to about 1,210,983 from about 36,329,490.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL8ykBDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630997603","title":"Aspire Biopharma launches USD 5 million share buyback program","url":"https://stock-news.laohu8.com/highlight/detail?id=2630997603","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630997603?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:31","pubTimestamp":1777293114,"startTime":"0","endTime":"0","summary":"Aspire Biopharma authorized a share repurchase program of up to USD 5 million.Buybacks may be executed through open-market purchases or privately negotiated transactions.Funding expected to come from existing cash on hand.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL1c82Rq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628290517","title":"Aspire Biopharma closes final tranche of $21M private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2628290517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628290517?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:15","pubTimestamp":1776694512,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) closed the second and final tranche of the private placement announced on February 11 for the purchase and sale of 26,250 s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-closes-final-tranche-of-21m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-closes-final-tranche-of-21m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628728718","title":"Aspire Biopharma secures commitment letter for up to $22.5 million DCS acquisition loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2628728718","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628728718?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:31","pubTimestamp":1776688290,"startTime":"0","endTime":"0","summary":"Aspire Biopharma entered a letter of intent dated April 15, 2026 to buy Dura Control Systems  for USD 30 million in cash.DCS is described as a global automotive driver control systems supplier with FY2025 revenue above USD 200 million.DCS delivered more than USD 20 million of adjusted EBITDA on that revenue base, on an unaudited basis.Aspire secured a commitment letter for a senior secured credit facility of up to USD 22.5 million to finance the proposed acquisition.Facility is structured as a five-year term loan priced at 325 basis points over one-month term SOFR.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2s1KSV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628206688","title":"Buzz Bomb brand ambassador to attempt fastest 100-mile treadmill run","url":"https://stock-news.laohu8.com/highlight/detail?id=2628206688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628206688?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:15","pubTimestamp":1776428144,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) announced that elite ultra-marathoner and BUZZ BOMB Global Brand Ambassador Ashley Paulson will attempt to shatter the fema...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/buzz-bomb-brand-ambassador-to-attempt-fastest-100-mile-treadmill-run-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/buzz-bomb-brand-ambassador-to-attempt-fastest-100-mile-treadmill-run-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628724546","title":"Aspire Biopharma stockholders approve charter amendments for potential reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2628724546","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628724546?lang=en_us&edition=fundamental","pubTime":"2026-04-17 03:23","pubTimestamp":1776367392,"startTime":"0","endTime":"0","summary":"Aspire Biopharma stockholders held a special meeting on April 10, 2026.Shareholders backed a charter amendment authorizing a reverse stock split, with a ratio range of 1-for-5 to 1-for-500 set at board discretion within one year.Approval was also granted for issuance of common shares issuable on conversion of Series A Convertible Preferred Stock, including conversion shares above the 19.99% threshold, with a conversion floor price set at 20% of the Minimum Price.Shareholders also approved an amendment to increase authorized common shares to 700,000,000, alongside authority to adjourn the meeting if needed to solicit additional proxies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL3GsSHq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627750218","title":"Aspire Biopharma Holdings Inc - Enters Letter of Intent to Buy Dura Driver Control Systems - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627750218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627750218?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:35","pubTimestamp":1776342900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nFWN40Z0UQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627184072","title":"Aspire Biopharma signs LOI to buy automotive supplier Dura Driver Control Systems for $30 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627184072","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627184072?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:30","pubTimestamp":1776342629,"startTime":"0","endTime":"0","summary":"Aspire Biopharma entered a letter of intent to acquire Dura Driver Control Systems, a tier-one automotive driver control systems supplier.Deal terms call for Aspire to buy 100% of DCS for USD 30 million in cash, subject to due diligence.DCS generated more than USD 200 million in FY2025 revenue, based on unaudited results.Adjusted EBITDA exceeded USD 20 million in FY2025, with net income above USD 17 million.DCS operates 11 facilities globally and holds more than 310 patents, supporting over 150 vehicle platforms.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLc2L7Wg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627466231","title":"BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2627466231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627466231?lang=en_us&edition=fundamental","pubTime":"2026-04-16 01:35","pubTimestamp":1776274543,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI SystemsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL6N40Y0QD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DTIL","UNP","PDSB","IONQ","AVGW","LLYX","GLOO","AVGO","BAC","NOV","TEM","TE","ALLO","LLY","TNGX","NKE","RGTI","EGBN","ABUS","HOOD","GTLB","SPRY","ASBP","NVDL","RVMD","ANV","SNVD.UK","KMX","NXL","FNB","NVDA","QUBT","BORR","WULF","NRXP","CSX","NVDD","WINA","OSIS","SYRE","NEM","AEO","BIRD","NVDY","NVDW","STNE","FHN","PNC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627028193","title":"Aspire subsidiary Buzz Bomb signs Interwest brokerage deal for Intermountain West expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2627028193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627028193?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:00","pubTimestamp":1776254457,"startTime":"0","endTime":"0","summary":"Aspire Biopharma subsidiary Buzz Bomb Caffeine entered sales and marketing brokerage agreement with Interwest Brokerage to expand retail distribution.Interwest will lead BUZZ BOMB sales, marketing, and distribution across Utah, Idaho, and Montana.Deal targets faster penetration in grocery, convenience, and alternate channels across Intermountain West.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL7y7NSD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627281659","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2627281659","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627281659?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:59","pubTimestamp":1776254342,"startTime":"0","endTime":"0","summary":"HeartBeam  shares were down 27% in Wednesday premarket activity, a day after the company said it priced a public offering of 12.5 million of its common shares for $10 million in total gross proceeds.Aspire Biopharma  stock was about 27% lower after the company said it signed a letter of intent to acquire Driver Controls Systems' business unit of Firefish Topco.BRP  shares were down over 23% after the company said overnight it was suspending its full-year 2027 guidance following a recent amendment to US rules for tariffs on steel, aluminum, and copper imports, which became effective earlier this month.TeraWulf  stock was 7.5% lower after the company said late Tuesday that it priced a public offering of 47.4 million shares at $19 each for gross proceeds of about $900 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","ASBP","BEAT","DOO","BK4190","WULF","WULX","BK4082","BK4595","BK4007","BK4600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627830972","title":"Aspire Biopharma signs LOI to buy Firefish Topco’s Driver Controls Systems unit for $30 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627830972","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627830972?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:34","pubTimestamp":1776249267,"startTime":"0","endTime":"0","summary":"Aspire Biopharma entered non-binding letter of intent dated April 15, 2026 to acquire 100% of Driver Controls Systems business unit of Firefish Topco.LOI sets enterprise valuation at $30 million on cash-free, debt-free basis, payable in cash at closing with customary adjustments.Transaction includes $3.5 million break-up fee payable by either side under specified circumstances.Sellers agreed to 30-day no-shop period, subject to possible extension.Post-closing plan calls for Lakewood & Company to provide management services for DCS, subject to separate definitive agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electron","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL3ln5w5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627746283","title":"Aspire Biopharma Holdings Inc - Deal Valued at $30 Mln, Payable in Cash at Closing - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627746283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627746283?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:31","pubTimestamp":1776249078,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0BG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627628372","title":"Aspire Biopharma Holdings Inc - Enters Non-Binding Loi to Buy 100% of Driver Controls Systems From Firefish Topco - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627628372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627628372?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:31","pubTimestamp":1776249078,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aspirebiolabs.com","stockEarnings":[{"period":"1week","weight":0.1874},{"period":"1month","weight":-0.0544},{"period":"3month","weight":-0.848},{"period":"6month","weight":-0.9455},{"period":"1year","weight":-0.987},{"period":"ytd","weight":-0.962}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.054},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.1098},{"period":"1year","weight":0.2815},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PowerUp Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on video gaming, gaming adjacent, and metaverse businesses. PowerUp Acquisition Corp. was incorporated in 2021 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.11488},{"month":2,"riseRate":0.5,"avgChangeRate":-0.30463},{"month":3,"riseRate":0.25,"avgChangeRate":-0.216086},{"month":4,"riseRate":0.5,"avgChangeRate":-0.260922},{"month":5,"riseRate":0.4,"avgChangeRate":-0.032731},{"month":6,"riseRate":0.8,"avgChangeRate":-0.054262},{"month":7,"riseRate":0.75,"avgChangeRate":0.106788},{"month":8,"riseRate":0.75,"avgChangeRate":0.136896},{"month":9,"riseRate":0.5,"avgChangeRate":-0.137877},{"month":10,"riseRate":0.75,"avgChangeRate":0.199866},{"month":11,"riseRate":0.5,"avgChangeRate":-0.177747},{"month":12,"riseRate":1,"avgChangeRate":0.063987}],"exchange":"NASDAQ","name":"Aspire Biopharma Holdings Inc.","nameEN":"Aspire Biopharma Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aspire Biopharma Holdings Inc.(ASBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aspire Biopharma Holdings Inc.,ASBP,Aspire Biopharma Holdings Inc.股票,Aspire Biopharma Holdings Inc.股票老虎,Aspire Biopharma Holdings Inc.股票老虎国际,Aspire Biopharma Holdings Inc.行情,Aspire Biopharma Holdings Inc.股票行情,Aspire Biopharma Holdings Inc.股价,Aspire Biopharma Holdings Inc.股市,Aspire Biopharma Holdings Inc.股票价格,Aspire Biopharma Holdings Inc.股票交易,Aspire Biopharma Holdings Inc.股票购买,Aspire Biopharma Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aspire Biopharma Holdings Inc.(ASBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}